Huntsman Cancer Institute/ University of Utah
Salt Lake City, Utah, 84112, United States
Location status: Recruiting
Location contact
Chelsey Schlechter, MPH, PhD
PRINCIPAL_INVESTIGATOR
Indy Li, MS
CONTACT
NCT Number: NCT07716280
The long-term goal of this program of research is to increase the reach of Lung Cancer Screening (LCS) among low-resource healthcare settings and populations. The proposed project, LUNG-IS, is a mixed-methods, pre-post quasi-experimental design conducted in three Utah safety-net healthcare system clinics.
LUNG-IS employs a comprehensive conceptual model with theories, models, and frameworks of implementation and behavioral science, uses rigorous mixed-methods to evaluate factors that influence implementation of LCS, and uses patient navigation to facilitate clinic-community linkages.
LUNG-IS leverages existing pathways to care and Centralized Hub infrastructure that enables eligibility assessment, LCS Shared Decision Making (SDM) with clinical decision support, screening referral, and screening logistics assistance to help overcome barriers to LCS completion. The Centralized Hub model uses ubiquitous technologies (i.e., text messaging/telehealth) to enable patients to be assessed for LCS eligibility, engage in SDM if eligible, and be referred for LCS. For patients who decide to complete LCS, they will be provided patient navigation via Community Health Workers designed to address logistical barriers, hesitancy, and financial constraints around completing LCS.
Interested in participating?
Request Info50 year–80 year
All sexes
Interventional
Not applicable
Salt Lake City, Utah, 84112, United States
Location status: Recruiting
Chelsey Schlechter, MPH, PhD
PRINCIPAL_INVESTIGATOR
Indy Li, MS
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Basic text messages sent directly to the patient's cell phone.
Chat bot to answer frequently asked LCS questions.
Educational video about LCS.
Reactive patient navigation to help get to the LCS appointment.
Proactive patient navigation to help get to the LCS appointment.
Time frame: up to 15 weeks after study enrollment
Evaluate the impact of implementation strategies on Lung Cancer Screening (LCS) eligibility screening. This outcome measure will report the proportion of participants who complete LCS eligibility screening.
Time frame: up to 7 weeks after completion of LCS eligibility screen
Evaluate the impact of implementation strategies on Shared Decision Making (SDM) completion. This outcome measure will report the proportion of patients who complete SDM.
Time frame: up to 6 months after placement of LCS referral
Evaluate the impact of implementation strategies on LCS completion. This outcome measure will report the proportion of participants who complete LCS.
Contact information is provided by the study sponsor or research team.
University of Utah
Other
Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics (LUNG-IS) - PATIENT
Acronym: LUNG-IS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06540196
Bronchial Neoplasms, Carcinoma, Bronchogenic
Hamilton, Ontario, Canada
View Trial DetailsNCT06410300
Lung Cancer, Lung Diseases
Columbia, Missouri, United States
View Trial DetailsNCT01441089
Adnexal Diseases, Breast Cancer
Bethesda, Maryland, United States
View Trial DetailsNCT00034216
Breast Cancer, Breast Diseases
Bethesda, Maryland, United States
View Trial Details